TOFACITINIB CITRATE (tofacitinib citrate) by Aurobindo Pharma is (jak) inhibitor. Approved for intolerance to one, more tnf blockers, older with: • active psa and 2 more indications. First approved in 2021.
Drug data last refreshed 18h ago
(JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoiesis and immune cell function. Within the signaling pathway, JAKs phosphorylate and activate…
Worked on TOFACITINIB CITRATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.